asymmetric reduction of prochiral ketones, with catecholborane as the hydride source. Enantioface differentiation is on the basis of the steric requirements of the ketone substituents. Aryl/ n-alkyl ketones are reduced in 90-93% ee and RC(O)Me (e.g. R = iPr, cycloC6H11, tBu) in 60-72% ee. Other borane sources and alternative catalyst structures based on indium do not form enantioselective catalysts
BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF
申请人:SENOMYX, INC.
公开号:US20160376263A1
公开(公告)日:2016-12-29
The present invention includes compounds and compositions known to modify the perception of bitter taste, and combinations of said compositions and compounds with additional compositions, compounds, and products. Exemplary compositions comprise one or more of the following: cooling agents; inactive drug ingredients; active pharmaceutical ingredients; food additives or foodstuffs; flavorants, or flavor enhancers; food or beverage products; bitter compounds; sweeteners; bitterants; sour flavorants; salty flavorants; umami flavorants; plant or animal products; compounds known to be used in pet care products; compounds known to be used in personal care products; compounds known to be used in home products; pharmaceutical preparations; topical preparations; cannabis-derived or cannabis-related products; compounds known to be used in oral care products; beverages; scents, perfumes, or odorants; compounds known to be used in consumer products; silicone compounds; abrasives; surfactants; warming agents; smoking articles; fats, oils, or emulsions; and/or probiotic bacteria or supplements.
activities (up to 9800 TON; TON=turnover number), broad substrate scope (81 examples), good functional‐group tolerance, and excellent enantioselectivities (85–98 % ee) in the hydrogenation of various ketones. These aspects are rare in earth‐abundant metal catalyzed hydrogenations. The utility of the protocol have been demonstrated in the asymmetric synthesis of a variety of key intermediates for chiral drugs
已经开发了一系列含有基于核苷的手性钳式配体的Mn I配合物,这些配合物具有模块化和可调的结构。该配合物在各种酮的氢化反应中显示出前所未有的高活性(高达9800 TON; TON =周转数),广泛的底物范围(81个实例),良好的官能团耐受性和出色的对映选择性(85-98%ee)。这些方面在稀土金属催化的氢化反应中很少见。该协议的实用性已在手性药物的多种关键中间体的不对称合成中得到证明。初步的机理研究表明,底物与催化剂相互作用的外层模式可能主导了催化作用。
Reductive biotransformation of carbonyl compounds—application of fungus, Geotrichum sp. G38 in organic synthesis
作者:Gu Jian-Xin、Li Zu-Yi、Lin Guo-Qiang
DOI:10.1016/s0040-4020(01)87947-3
日期:1993.6
The microbial transformation of 2- and 3-oxo esters and diketones with Geotrichum sp. G38 and its application to the syntheses of the key intermediates of several bioactive compounds such as (R)-denopamine 8, (R)-fluoxetine 11 and (2S, 3R)-sitophilate 14 were described.